Which closed-end funds own Madrigal Pharmaceuticals Inc?
4 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $2.1M. Security type: common equity. Country: United States. CUSIP 558868105 · ISIN US5588681057 · ticker MDGL.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BME BlackRock Health Sciences Trust | Healthcare | 0.23% | $1.3M | 2,494 sh | $573M | 3.7% discount | Jun 30, 2026 |
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 0.07% | $161K | 300 sh | $228M | NAV unavailable | Jun 30, 2026 |
| QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund | Covered Call / Option Income | 0.05% | $869K | 1,618 sh | $1.6B | 3.8% discount | Jun 30, 2026 |
| CPZ Calamos Long/Short Equity & Dynamic Income Trust | U.S. Equity | -0.11% | $-291K | -622 sh | $259M | 15.9% discount | Jul 31, 2026 |
4 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: MADRIGAL PHARMACEUTICALS INC.
Issuer-level search for “MDGL” → · Compare two funds’ portfolios →